focus -WSS

focus

author：knowledge 2025-09-06 20:45:48 - browse：716

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Sanofi strikes deal with Novavax, boosting the vaccine maker

hotspot

WSS

Use wet bulb globe temperature, not heat index, to protect workers

Questions and answers about ramping up H5N1 bird flu vaccine

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Use wet bulb globe temperature, not heat index, to protect workers

Addressing health care workers' trauma can help fight burnout

Readout LOUD podcast: brain research, obesity drug sales, Novartis

hotspot

focus

leisure time

Psychedelics group wrestles with new pharma identity

H5N1 bird flu: what we're starting to learn about infection in cows

Anesthesiologist group: stop taking Ozempic before surgery

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Investigation reveals sickle cell patients pressured into sterilizations

Activists slam private health insurers over coverage restrictions

Making AI in medicine accessible to smaller, and rural hospitals

As demand for Covid shots wanes, Moderna seeks its next success

Liver decline slowed by off

entertainment

Study: AI not yet building 'n

Addressing health care workers' trauma can help fight burnout

Biogen joins immunology wave with $1.15 billion acquisition of HI

Digital health: a case of mistaken identity

Study: AI not yet building 'n

Readout LOUD podcast: brain research, obesity drug sales, Novartis

focus

entertainment

hotspot

explore